Gene · 23400
Papers1,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pediatric onset neuronal ceroid lipofuscinoses: Unraveling clinical and genetic specifications. | Pak J Med Sci | 2024 | 39281238 | PubTator, text mining | PubMed |
| Effects of Monaural Temporal Electrode Asynchrony and Channel Interactions in Bilateral and Unilateral Cochlear-Implant Stimulation. | Trends Hear | 2024 | 39215517 | PubTator, text mining | PubMed |
| Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia. | Mov Disord | 2024 | 39149795 | PubTator, text mining | PubMed |
| Association between inflammatory bowel disease and osteoporosis in European and East Asian populations: exploring causality, mediation by nutritional status, and shared genetic architecture. | Front Immunol | 2024 | 39136019 | PubTator, text mining | PubMed |
| Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primates. | NPJ Parkinsons Dis | 2024 | 39090150 | PubTator, text mining | PubMed |
| Parkinson's Disease Gene Screening in Familial Cases from Central and South America. | Mov Disord | 2024 | 39051491 | PubTator, text mining | PubMed |
| Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities. | NPJ Parkinsons Dis | 2024 | 39030200 | PubTator, text mining | PubMed |
| Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy. | Neurogenetics | 2024 | 39023817 | PubTator, text mining | PubMed |
| Multi-tissue transcriptome-wide association study identifies novel candidate susceptibility genes for cataract. | Front Ophthalmol (Lausanne) | 2024 | 38984127 | PubTator, text mining | PubMed |
| Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells. | J Immunol | 2024 | 38950331 | PubTator, text mining | PubMed |
| Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning. | Front Endocrinol (Lausanne) | 2024 | 38800474 | PubTator, text mining | PubMed |
| Genetic heterogeneity in epilepsy and comorbidities: insights from Pakistani families. | BMC Neurol | 2024 | 38783254 | PubTator, text mining | PubMed |
| Iron metabolism disorder and multiple sclerosis: a comprehensive analysis. | Front Immunol | 2024 | 38590521 | PubTator, text mining | PubMed |
| Cervical Dystonia Caused by Variant of ATP13A2 Responsive to Subthalamic Deep Brain Stimulation. | Mov Disord | 2024 | 38586886 | PubTator, text mining | PubMed |
| Correction to: ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function. | Hum Mol Genet | 2024 | 38512067 | PubTator, text mining | PubMed |
| Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications. | Neurotox Res | 2024 | 38319410 | PubTator, text mining | PubMed |
| Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S. | Biology (Basel) | 2024 | 38275734 | PubTator, text mining | PubMed |
| Polyamine Signal through HCC Microenvironment: A Key Regulator of Mitochondrial Preservation and Turnover in TAMs. | Int J Mol Sci | 2024 | 38256070 | PubTator, text mining | PubMed |
| Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease. | Biomolecules | 2024 | 38254673 | PubTator, text mining | PubMed |
| A novel ATP13A2 variant causing complicated hereditary spastic paraplegia. | Neurol Sci | 2024 | 38252374 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23400/papers?page=5